82 results on '"Feinstein, James A"'
Search Results
2. Recurrent Intensive Care Episodes and Mortality Among Children With Severe Neurologic Impairment
3. Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid
4. Major Drug–Drug Interaction Exposure Among Medicaid-Insured Children in the Outpatient Setting
5. An mHealth design to promote medication safety in children with medical complexity
6. Preparing for the International Classification of Diseases, 11th Revision (ICD-11) in the US Health Care System
7. Positive Predictive Value of ICD-10 Codes to Identify Acute Suicidal and Self Harm Behaviors
8. Ontologizing health systems data at scale: making translational discovery a reality
9. Characteristics Associated With Serious Self-Harm Events in Children and Adolescents
10. A coordinated approach for managing polypharmacy among children with medical complexity: rationale and design of the Pediatric Medication Therapy Management (pMTM) randomized controlled trial
11. Making Polypharmacy Safer for Children with Medical Complexity
12. Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa
13. Anticholinergic Medications and Parent-Reported Anticholinergic Symptoms in Neurologically Impaired Children
14. Polypharmacy among medicaid‐insured children with and without documented obesity
15. Clinical characteristics of children with severe neurologic impairment: A scoping review
16. Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa
17. Identifying opportunities for pediatric medication therapy management in children with medical complexity
18. Guideline-Concordant Antiviral Treatment in Children at High Risk for Influenza Complications
19. Validation of Neurologic Impairment Diagnosis Codes as Signifying Documented Functional Impairment in Hospitalized Children
20. Identifying Acute Neuropsychiatric Events in Children and Adolescents
21. Trends in Health Care Use and Spending for Young Children With Neurologic Impairment
22. Intervention research to improve care and outcomes for children with medical complexity and their families
23. Medications Reconciled at Discharge Versus Admission Among Inpatients at a Children’s Hospital
24. Complexity of Medication Regimens for Children With Neurological Impairment
25. Readmissions Following Hospitalization for Infection in Children With or Without Medical Complexity
26. Hospitalization Outcomes for Rural Children with Mental Health Conditions
27. Timing of Co-occurring Chronic Conditions in Children With Neurologic Impairment
28. Perceived Versus Demonstrated Understanding of the Complex Medications of Medically Complex Children
29. Parent-Reported Symptoms and Medications Used Among Children With Severe Neurological Impairment
30. Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database
31. Identifying Important Clinical Symptoms in Children With Severe Neurological Impairment Using Parent-Reported Outcomes of Symptoms
32. Prevalence of Clinically Significant Drug-Drug Interactions Across US Children’s Hospitals
33. Asthma
34. Contributors
35. Medical and Psychological Sequelae of Child Abuse and Neglect
36. Health Care Utilization and Spending for Children With Mental Health Conditions in Medicaid
37. A Scoping Review of Medications Studied in Pediatric Polypharmacy Research
38. Inpatient Databases
39. Identification of Children With High-Intensity Neurological Impairment
40. Outcome measures in pediatric polypharmacy research: a scoping review
41. Outpatient Prescription Opioid Use in Pediatric Medicaid Enrollees With Special Health Care Needs
42. Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discovery
43. Data Science for Child Health
44. Chronic Medication Use in Children Insured by Medicaid: A Multistate Retrospective Cohort Study
45. Management of Self‐injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy Overview
46. Variation of the prevalence of pediatric polypharmacy: A scoping review
47. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America
48. Choosing medications wisely: Is it time to address paediatric polypharmacy?
49. Approach and Safety of Esophageal Dilation for Treatment of Strictures in Children With Epidermolysis Bullosa
50. Defining pediatric polypharmacy: A scoping review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.